Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

Like other commissions set up by Congress—such as the Cyberspace Solarium Commission that provided crucial cybersecurity measures—the National Security Commission on Emerging Biotechnology (NSCEB) was ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...

A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway. A planning ...

How well do you remember this year’s headlines? In just a couple of weeks, we’ll be bidding farewell to 2025. And what a year it has been! Artificial intelligence is being incorporated into more ...

In a major boost to Nigeria’s capacity to tackle climate change and food insecurity, the JR Biotek Foundation, Mastercard Foundatio, and the University of Cambridge have partnered the Michael Okpara ...